Back to Search
Start Over
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparumparasite resistance
- Source :
- Science Translational Medicine; July 2021, Vol. 13 Issue: 603 peabg6013
- Publication Year :
- 2021
-
Abstract
- We report an acylguanidine preclinical candidate with pharmacological features compatible with single low-dose malaria cure.
Details
- Language :
- English
- ISSN :
- 19466234 and 19466242
- Volume :
- 13
- Issue :
- 603
- Database :
- Supplemental Index
- Journal :
- Science Translational Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs57196707
- Full Text :
- https://doi.org/10.1126/scitranslmed.abg6013